Objective: To compare the use of mirabegron with anticholinergics drugs for the treatment of overactive bladder (OB).
Data Source: Systematic searches were conducted in EMBASE, PUBMED, Cochrane, and LILACS databases from inception to September 2021. We included RCTs, women with clinically proven OB symptoms, studies that compared mirabegron to antimuscarinic drugs, and that evaluated the efficacy, safety or adherence.